The question is moving from what AI can do to how anyone can check it. The MHRA says AI medical devices will need ongoing monitoring after approval; AI Airlock phase 3 opens, with a full roadmap due by spring 2027.
What the government accepted
On Tuesday 6 October, the UK government said it will accept all 44 recommendations from the National Commission into the Regulation of AI in Healthcare, published 10 September. A draft implementation plan is expected by the end of the year and a full roadmap by spring 2027.
MHRA chief executive Lawrence Tallon told Reuters that AI medical devices will need constant monitoring after approval rather than a single pre-approval check, describing "a much more sophisticated and complex era of AI as a medical device where we have non-deterministic algorithms."
What opens next
The MHRA also opened applications for phase 3 of AI Airlock, its regulatory sandbox, focused on post-market surveillance; applications close in November with an applicant webinar on 22 October. The UK regulator's direction is checking AI throughout its working life, not only at sign-off.
Coverage context
All 44 healthcare AI recommendations are now accepted, with the MHRA putting post-approval monitoring — not a single check — on the public record, and AI Airlock phase 3 opening for post-market surveillance.
Read the full daily brief hub: www.aifusionautomations.com/news/